Relation of CagA seropositivity to cagPAI phenotype and histological grade of gastritis in patients with Helicobacter pylori infection

World Journal of Gastroenterology

Volumn 11, Issue 24, 2005, Pages 3751-3755

  Shimoyama, Tadashi ^a   Fukuda, Shinsaku ^a   Nakasato, Fumika ^a   Yoshimura, Tetsuro ^a   Mikami, Tatsuya ^a   Munakata, Akihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

CagA seropositivity; cagPAI; Gastric Inflammation

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; CAGE PROTEIN; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRD4 PROTEIN;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATORY INFILTRATE; INTERMETHOD COMPARISON; JAPAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENICITY ISLAND; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTION; SENSITIVITY ANALYSIS; SERODIAGNOSIS; STOMACH BIOPSY;

EID: 23844438917     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i24.3751     Document Type: Article

References (27)

1. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-14653
2. Odenbreit S, Gebert B, Puls J, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287: 1497-1500
3. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5795
4. Crabtree JE, Farmery SM. Helicobacter pylori and gastric mucosal cytokines: evidence that CagA-positive strains are more virulent. Lab Invest 1995; 73: 742-745
5. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-1268
6. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-686
7. Li SD, Kersulyte D, Lindley IJD, Neelam B, Berg DE, Crabtree JE. Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells. Infect Immun 1998; 67: 3893-3899
8. Crabtree JE, Kersulyte D, Li SD, Lindley IJ, Berg DE. Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue. J Clin Pathol 1999; 52: 653-657
9. Shimoyama T, Everett SM, Dixon MF, Axon AT, Crabtree JE. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol 1998; 51: 765-770
10. Krausse R, Garten L, Harder T, Ullmann U, Birkner T, Doniec M, Grimm H. Clinical relevance of CagA-specific antibodies related to CagA status of Helicobacter pylori isolates using immunofluorescence test and PCR. Infection 2001; 29: 154-158
11. Peters TM, Owen RJ, Slater E, Varea R, Teare EL, Saverymuttu S. Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia. J Clin Pathol 2001; 54: 219-223
12. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A. High prevalence of the cagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 1997; 32: 465-468
13. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Cover TL, Atherton JC, Dunn GD, Blaser MJ. Detection of Helicobacter pylori gene expression in human gastric mucosa. J Clin Microbiol 1995; 33: 28-32
14. Maeda S, Akanuma M, Mitsuno Y, Hirata Y, Ogura K, Yoshida H, Shiratori Y, Omata M. Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem 2001; 276: 44856-44864
15. Slater E, Owen RJ, Williams M, Pounder RE. Conservation of the cag pathogenicity island of Helicobacter pylori: Associations with vacuolating cytotoxin allele and IS605 diversity. Gastroenterology 1999; 117: 1308-1315
16. Umegaki N, Shimoyama T, Nishiya D, Suto T, Fukuda S, Munakata A. Clarithromycin-resistance and point mutations in the 23SrRNA gene in Helicobacter pylori isolates from Japan. J Gastroenterol Hepatol 2000; 15: 906-909
17. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Munakata A, Crabtree JE. CagA seropositivity associated with development of gastric cancer in a Japanese population. J Clin Pathol 1998; 51: 225-228
18. Neelam B, Davies G, Wyatt JI, Crabtree JE. Evaluation of a new immunoblot assay using recombinant proteins for the detection of antibodies to Helicobacter pylori. Gut 1998; 42 (Suppl 1): A81
19. Selbach M, Moese S, Meyer TF, Backert S. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun 2002; 70: 665-671
20. Tummuru MK, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995; 18: 867-876
21. Maeda S, Anarsanaa J, Mitsuno Y, Hirata Y, Akanuma M, Ikenoue T, Ogura K, Yoshida H, Shiratori Y, Omata M, Anarsanaa J. Relationship between nuclear factor-kappaB activation and virulence factors of Helicobacter pylori in Japanese clinical isolates. J Gastroenterol Hepatol 2002; 17: 556-562
22. Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, Yoshida H, Shiratori Y, Omata M. Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diag Lab Immunol 2001; 8: 181-186
23. Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, Shiratori Y, Omata M. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999; 44: 336-341
24. Miehlke S, Go MF, Kim JG, Graham DY, Figura N. Serologic detection of Helicobacter pylori infection with cagA-positive strains in duodenal ulcer, gastric cancer, and asymptomatic gastritis. J Gastroenterol 1998; 33(Suppl 10): 18-21
25. Basso D, Stefani A, Brigato L, Navaglia F, Greco E, Zambon CF, Piva MG, Toma A, Di Mario F, Plebani M. Serum antibodies anti-H pylori and anti-CagA: a comparison between four different assays. J Clin Lab Anal 1999; 13: 194-198
26. Maeda S, Yoshida H, Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, Tagawa H, Kawaguchi R, Mori K, Mafune K, Kawabe T, Shiratori Y, Omata M. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunosorbent assay (ELISA) versus commercially available H pylori ELISAs. Cancer 2000; 88: 1530-1535
27. Yamaoka Y, Kodama T, Kashima K, Graham DY. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol 1999; 52: 215-218